In Action
Our Benefits
Manufacturing & Shipping significantly reduces the carbon footprint vs Needle & Syringe
Vaccines – Providing a much Cleaner Next-Gen Technology
Supported by data from a PATH Vaccine Technology Impact Assessment
Shipping Economy & Logistics Efficiency
Provides material storage & transportation cost reductions
c.1.3 Million a VaxziPen solid doses In a Standard 20ft Shipping Container
c.55,000 a VaxziPen solid doses
Cold chain free
c. 2,000 a VaxziPen solid doses could be carried in a 30L medical bag with no coolant required and remain stable at 50°C for up to 1 year
c.220,000 liquid vaccine doses* in a Medical Grade Cold Chain
20ft Shipping Container
c.11,000 liquid vaccine doses*
Requiring end to end cold chain storage (e.g. refrigerated shipping container)
c.105 vaccine doses* with required number of vials/needles/syringes/ice blocks in a 30L medical cool bag and remain stable at 2-8°C for up to 7 hours
*For a reconstituted single-dose vial vaccine. (Container quantities assume standard 1.2m x 1.2m x 1m pallets stacked floor to ceiling)